MY PKU: Increasing self-management in patients with phenylketonuria. A randomized controlled trial

Orphanet Journal of Rare Diseases

Volumn 6, Issue 1, 2011, Pages

  Ten Hoedt, Amber E ^a   Hollak, Carla E M ^a   Boelen, Carolien C A ^b   Van Der Herberg Van De Wetering, N Ada P ^b   Ter Horst, Nienke M ^a   Jonkers, Cora F ^a   Wijburg, Frits A ^a   Bosch, Annet M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIET THERAPY; DIETITIAN; E-MAIL; FEMALE; FOLLOW UP; HUMAN; INFANT; MALE; ONLINE SYSTEM; OUTCOME ASSESSMENT; PARENT; PATIENT SATISFACTION; PHENYLKETONURIA; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SELF CARE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIET;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DIET; FEMALE; HUMANS; INFANT; MALE; PATIENT SATISFACTION; PHENYLALANINE; PHENYLKETONURIAS; SELF CARE; YOUNG ADULT;

EID: 79959568957     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-6-48     Document Type: Article

References (24)

1. Hyperphenylalaninemia: Phenylalanine Hydroxylase Deficiency in The Online Metabolic and Molecular Bases of Inherited Disease. R Scriver H Levy J Donlon, http://www.ommbid.com/OMMBID/the-online-metabolic-and-molecular-bases-of- inherited-disease/b/fulltext/part8/ch77
2. Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis. SE Waisbren K Noel K Fahrbach C Cella D Frame A Dorenbaum H Levy, Mol Genet Metab 2007 92 63 70 10.1016/j.ymgme.2007.05.006 17591452 (Pubitemid 47361886)
3. Sustained attention and inhibition of cognitive interference in treated phenylketonuria: associations with concurrent and lifetime phenylalanine concentrations. SC Huijbregts LM de Sonneville R Licht FJ van Spronsen PH Verkerk JA Sergeant, Neuropsychologia 2002 40 7 15 10.1016/S0028-3932(01)00078-1 11595258 (Pubitemid 32929971)
4. Recommendations on the dietary management of phenylketonuria. Report of Medical Research Council Working Party on Pheylketonuria, Arch Dis Child 1993 68 426 427 8466250
5. Phenylketonuria: Screening and Management. National Institutes of Health Consensus Development Conference Statement, Pediatrics 2001 108 972 982 11581453
6. Management of phenylketonuria in Europe: survey results from 19 countries. N Blau A Bélanger-Quintana M Demirkol F Feillet M Giovannini A MacDonald FK Trefz F van Spronsen European PKU centers, Mol Genet Metab 2010 99 109 115 10.1016/j.ymgme.2009.09.005 19800826
7. Survey of national guidelines for the treatment of phenylketonuria. S Schweitzer-Krantz P Burgard, Eur J Pediatr 2000 159 70 73 10.1007/PL00014385 11043148
8. The reality of dietary compliance in the management of phenylketonuria. A Macdonald H Gokmen-Ozel M van Rijn P Burgard, J Inherit Metab Dis 2010
9. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. L McAndrew SH Schneider E Burns H Leventhal, Diabetes Educ 2007 33 991 1011 10.1177/0145721707309807 18057267
10. Self-management of anticoagulation. M Levi, Expert Rev Cardiovasc Ther 2008 6 979 985
11. Does self-monitoring reduce blood pressure? Meta-analysis with meta-regression of randomized controlled trials. EP Bray R Holder J Mant RJ McManus, Ann Med 2010 42 371 386 10.3109/07853890.2010.489567 20504241
12. Systematic review of studies of self-management of oral anticoagulation. A Siebenhofer A Berghold PT Sawicki, Thromb Haemost 2004 91 225 232 14961147 (Pubitemid 38240165)
13. Plasma phenylalanine in patients with phenylketonuria self-managing their diet. J Bekhof M van Rijn PJ Sauer EM Ten Vergert DJ Reijngoud FJ van Spronsen, Arch Dis Child 2005 90 163 164 10.1136/adc.2003.040451 15665170 (Pubitemid 40188014)
14. Towards self-monitoring and self-treatment in phenylketonuria-a way to better diet compliance. U Wendel U Langenbeck, Eur J Pediatr 1996 155 S1 105 107 10.1007/PL00014224
15. The hyperphenylalaninemias. CR Scriver S Kaufman E Eisensmith SLC Woo, The Metabolic and Molecular Bases of Inherited Disease New York: McGraw-Hill, Scriver CR, Beaudet AL, Sly WS, Valle D, 7 1995 1015 1075
16. Human phenylalanine hydroxylase mutations and hyperphenylalaninemia phenotypes: a metanalysis of genotype-phenotype correlations. E Kayaalp E Treacy PJ Waters S Byck P Nowacki CR Scriver, Am J Hum Genet 1997 61 1309 1317 10.1086/301638 9399896 (Pubitemid 28046907)
17. Phenylketonuria. N Blau FJ van Spronsen HL Levy, Lancet 2010 376 1417 1427 10.1016/S0140-6736(10)60961-0 20971365
18. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. SJ Pocock R Simon, Biometrics 1975 31 103 115
19. How practical are recommendations for dietary control in phenylketonuria? JH Walter FJ White SK Hall A MacDonald G Rylance A Boneh DE Francis GJ Shortland M Schmidt A Vail, Lancet 2002 360 55 57 10.1016/S0140-6736(02)09334-0 12114043 (Pubitemid 34756494)
20. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria. P Burgard E Schmidt A Rupp W Schneider HJ Bremer, Eur J Pediatr 1996 155 S1 33 38 10.1007/PL00014245 8828606
21. Meta-analysis of quality of life outcomes following diabetes self-management training. J Cochran VS Conn, Diabetes Educ 2008 34 815 823 10.1177/0145721708323640 18832286
22. Effects of an empowerment-based psychosocial intervention on quality of life and metabolic control in type 2 diabetic patients. M Pibernik-Okanovic M Prasek T Poljicanin-Filipovic I Pavlic-Renar Z Metelko, Patient Educ Couns 2004 52 193 199 10.1016/S0738-3991(03)00038-7 15132525 (Pubitemid 38169232)
23. Does self-management of oral anticoagulation therapy improve quality of life and anxiety? D McCahon ET Murray K Murray RL Holder DA Fitzmaurice, Fam Pract 2010 10
24. Discrepancy in Illness-related Goals and Quality of Life in Chronically Ill Patients: The Role of Self-efficacy. RG Kuijer DTD De Ridder, Psychol & Health 2003 18 313 330 21710639 (Pubitemid 36795317)